Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Singulair (Montelukast Sodium) Granules, 4 mg, Merck Research NDA 21-409/S3 12/31/02 1/23/03 4/9/03 Singulair (Montelukast Sodium) Granules, Merck Research NDA 21-409 7/26/02 8/6/02 7/30/02 Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Granules, Merck Research NDA 20-829/S23 & 20-830/S26 & 21-409/S5 10/2/03 10/9/03 10/10/03 Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Granules, 10 mg, 4 & 5 mg & 4 mg, Merck Research NDA 20-829/S17 & 20-830/S20 & 21-409/S3 12/31/02 1/23/03 4/7/03 Singulair (montelukast sodium) Chewable Tablets, Merck & Co., NDA 20-829/S12 08/02/01 08/02/01 Singulair (Montelukast Sodium) Tablets, Merck Research NDA 20-829 & 20-830 2/20/98 9/10/98 12/8/98 5/24/01 Singulair (Montelukast Sodium) Tablets, 10 mg, Merck Research NDA 20-829/S001 2/12/99 7/5/01 Singulair (Montelukast Sodium) Chewable Tablets, 5 mg, Merck Research NDA 20-830/S001 2/12/99 7/5/01 Singulair (Montelukast Sodium) Chewable Tablets, 4 mg, Merck NDA 20-830/S-8 3/3/00 9/7/01 Singulair (montelukast sodium) Chewable Tablets, Merck & Co. NDA 20-830/S-011 11/23/01 11/25/02 04/24/03 Singulair Indication: prophylaxis for asthma in children 2-5 years of age. Singulair (Montelukast Sodium) Tablets & Chewable Tablets, Merck Research Singulair (Montelukast Sodium) Tablets & Chewable Tablets & Oral Granules, Merck Research Laboratories | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Inc., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Oral Granules, Merck and Co., New or Modified Indication | Singulair (montelukast sodium) Oral Granules, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Tablets, Merck and Co., Efficacy Supplement w/Clinical Data | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., New or Modified Indication & Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., New or Modified Indication & Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., New or Modified Indication & Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tables, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Chewable Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck & Co., Labeling Revision | Singulair (montelukast sodium) Tablets, Merck and Co, Inc., Labeling Revision | Singulair (montelukast sodium) Chewable Tables, Merck and Co, Inc., Labeling Revision | Singulair (montelukast sodium) Oral Granules, Merck and Co, Inc., Labeling Revision | Montelukast Sodium Tablets, Teva Pharmaceuticals, Tentative Approval | Montelukast Sodium Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Montelukast Sodium Tablets, Roxane Laboratories, Inc., Tentative Approval | Montelukast Sodium Chewable Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Montelukast Sodium Tablets, Teva Pharmaceuticals, Tentative Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2009 Betterchem.com